ask="2.88"
ask_size="300"
average_daily_volume="238769"
bid="1.75"
bid_size="100"
book_value="3.15"
change="+0.08"
change_from_200_day_moving_average="-0.43"
change_from_50_day_moving_average="-0.32"
change_from_52_week_high="-6.34"
change_From_52_week_low="0.26"
change_in_percent="+4.28%"
close="1.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.70"
ebitda="-56.49M"
eps_estimate_current_year="-5.24"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="14620000"
high="1.96"
high_52_weeks="8.29"
last_trade_date="2/15/2017"
last_trade_price="1.95"
last_trade_size="1224"
last_trade_time="4:00pm"
low="1.87"
low_52_weeks="1.69"
market_capitalization="39.48M"
moving_average_200_day="2.38"
moving_average_50_day="2.27"
name="Aptevo Therapeutics Inc."
notes="N/A"
one_year_target_price="5.00"
open="1.87"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-18.00%"
percent_change_from_50_day_moving_average="-14.13%"
percent_change_from_52_week_high="-76.48%"
percent_change_from_52_week_low="+15.38%"
previous_close="1.87"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.59"
price_per_sales="1.05"
revenue="35.95M"
shares_outstanding="20248000"
short_ratio="3.50"
stock_exchange="NMS"
symbol="APVO"
volume="77469"
weeks_range_52="1.69 - 8.29"
